SCHEMBL3907324

SCHEMBL3907324

CCCCC(=CO)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.46
CES2 O00748 1/20 0.46
APEX1 P27695 1/20 0.44
ALDH1A1 P00352 3/20 0.42
AKR1B1 P15121 1/20 0.42
TP53 P04637 1/20 0.42
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 7/20 0.41
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41
PTPN1 P18031 3/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10445632 0.93 AKR1B1 (0.52) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL5169546 0.93 AKR1B1 (0.52) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL734471 0.91 GPR84 (0.54) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL2333734 0.85
SCHEMBL10713198 0.85
SCHEMBL481537 0.83 CES1 (0.48) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL88045 0.83 CES1 (0.48) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL1287562 0.83 CES1 (0.48) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL3344502 0.83 CES1 (0.48) CES1CES2APEX1ALDH1A1AKR1B1
SCHEMBL8089512 0.83 CES1 (0.48) CES1CES2APEX1ALDH1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584229-A1 AMINO COMPOUND-CONTAINING DISPERSION POWDER COMPOSITIONS Wacker Chemie AG (DE) 2025-07-16 EP claimed
WO-2024051931-A1 AMINO COMPOUND-CONTAINING DISPERSION POWDER COMPOSITIONS WACKER CHEMIE AG (DE) 2024-03-14 WO claimed
EP-0812336-B1 COATING COMPOSITION BASED ON A BINDER CONTAINING HYDROXYL GROUPS, AND ITS USE IN PROCESSES FOR THE PRODUCTION OF COATINGS BASF CORP (US) 2002-09-04 EP claimed
EP-0852609-B1 THREE-COMPONENT PAINT OF HIGH SOLVENT FASTNESS AND STRIP RESISTANCE BASF COATINGS AG (DE) 2002-03-13 EP claimed
EP-0885908-A1 Coating composition based on a polyacrylate resin containing hydroxyl groups, and its use in processes for the production of coatings BASF CORPORATION (US) 1998-12-23 EP claimed
EP-0748262-B1 POLY(METH-)ACRYLIC RESIN-BASED COATING AGENT WHICH CAN BE CROSS-LINKED WITH ISOCYANATE BASF COATINGS AG (DE) 1998-12-16 EP claimed
EP-0748262-A1 POLY(METH-)ACRYLIC RESIN-BASED COATING AGENT WHICH CAN BE CROSS-LINKED WITH ISOCYANATE BASF Lacke und Farben AG (DE) 1996-12-18 EP claimed
WO-1995023653-A1 POLY(METH-)ACRYLIC RESIN-BASED COATING AGENT WHICH CAN BE CROSS-LINKED WITH ISOCYANATE BASF LACKE + FARBEN AG (DE) 1995-09-08 WO claimed
US-12622970-B2 Photocurable reinforcement of 3D printed hydrogel objects LUNG BIOTECHNOLOGY PBC (US) 2026-05-12 US disclosed
EP-4441010-A1 PROCESS FOR PREPARING WATER-REDISPERSIBLE POLYMER POWDERS Wacker Chemie AG (DE) 2024-10-09 EP disclosed
EP-4333919-A1 PHOTOCURABLE REINFORCEMENT OF 3D PRINTED HYDROGEL OBJECTS Lung Biotechnology PBC (US) 2024-03-13 EP disclosed
CN-117157349-A Method for producing a coated molded body and use of a coated molded body 巴斯夫欧洲公司 2023-12-01 CN disclosed
US-11680371-B2 Method for producing multi-layer paper SOLENIS TECHNOLOGIES, L.P. (US) 2023-06-20 US disclosed
WO-2023098983-A1 PROCESS FOR PREPARING WATER-REDISPERSIBLE POLYMER POWDERS WACKER CHEMIE AG (DE) 2023-06-08 WO disclosed
EP-0071813-B1 SYNTHETIC RESIN BASF Lacke + Farben AG (DE) 1986-09-24 EP disclosed
EP-0071813-A2 Synthetic resin BASF Lacke + Farben AG (DE) 1983-02-16 EP disclosed
EP-0000608-B1 PROCESS FOR THE PREPARATION OF COPOLYMERS AND COATING COMPOSITIONS, SUCH AS BINDERS FOR LACQUERS, THAT ARE DISSOLVABLE IN ORGANIC SOLVENTS AND THAT CONTAIN HYDROXYL GROUPS HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-08 EP disclosed
US-4143020-A COPOLYMERS OF SULFONIC ACID MONOMERS ROHM AND HAAS COMPANY (US) 1979-03-06 US disclosed
EP-0000608-A1 Process for the preparation of copolymers and coating compositions, such as binders for lacquers, that are dissolvable in organic solvents and that contain hydroxyl groups HOECHST AKTIENGESELLSCHAFT (DE) 1979-02-07 EP disclosed
US-4131736-A Polymers of sulfonic acid monomers ROHM AND HAAS COMPANY (US) 1978-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622970-B2 Photocurable reinforcement of 3D printed hydrogel objects HTR3D, MTCL3, SMC3 CES1 4844/4885CES2 4830/4885APEX1 3264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.